SAREPTA THERAPEUTICS INC

CUSIP: 803607AB6 Class: DBCV 1.500%11/1

D. E. Shaw & Co., Inc.'s Holding History (CIK: 0001009207)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 11,371,000 Value ($000) $19,372 Avg Close — Range —
Q2 2024
Shares 11,371,000 Value ($000) $24,523 Avg Close — Range —
Q1 2024
Shares 11,371,000 Value ($000) $20,341 Avg Close — Range —
Q4 2023
Shares 11,371,000 Value ($000) $16,047 Avg Close — Range —
Q3 2023
Shares 11,089,000 Value ($000) $19,645 Avg Close — Range —
Q2 2023
Shares 7,606,000 Value ($000) $12,887 Avg Close — Range —
Q1 2023
Shares 4,100,000 Value ($000) $7,953 Avg Close — Range —
Q4 2022
Shares 14,147,000 Value ($000) $26,436 Avg Close — Range —
Q3 2022
Shares 14,147,000 Value ($000) $23,564 Avg Close — Range —
Q2 2022
Shares 29,192,000 Value ($000) $36,798 Avg Close — Range —
Q1 2022
Shares 34,217,000 Value ($000) $44,903 Avg Close — Range —
Q4 2021
Shares 40,217,000 Value ($000) $59,031 Avg Close — Range —
Q3 2021
Shares 45,717,000 Value ($000) $67,840 Avg Close — Range —
Q2 2021
Shares 51,217,000 Value ($000) $67,871 Avg Close — Range —
Q1 2021
Shares 45,717,000 Value ($000) $59,629 Avg Close — Range —
Q4 2020
Shares 36,217,000 Value ($000) $88,701 Avg Close — Range —
Q3 2020
Shares 33,744,000 Value ($000) $69,965 Avg Close — Range —
Q2 2020
Shares 20,500,000 Value ($000) $47,128 Avg Close — Range —